Jacksyl Group Investments is a registered entity operating in full compliance with SEC regulations governing private placements and syndications. Every offering is structured under Reg D exemptions (506(b) and 506(c)), which means the SEC has specific rules we must follow — including who we can accept capital from, how we document accreditation status, and what disclosures we must provide before any investment is made.

Before a single dollar changes hands, you will receive a Private Placement Memorandum (PPM) — a legally binding document that details every material fact about the deal, the risks, the fees, the conflicts of interest, and the legal structure. This is not a brochure. It is a disclosure document reviewed by securities attorneys and filed with the SEC. You are encouraged to have your own attorney or financial advisor review it.

We also understand that healthcare professionals are targeted by financial fraud at disproportionate rates. That skepticism is healthy, and we welcome it. Here is what you can verify independently: our entity registration, our track record of closed transactions, our operating agreements, and references from current investors who are also healthcare professionals. We do not ask you to trust us based on a conversation — we ask you to trust the documentation, the legal framework, and the verifiable evidence. Credibility is not claimed; it is demonstrated.

Every deal we have syndicated has a story — and we tell all of them, including the ones that didn't go exactly to plan. Our track record is available for your review and includes: the number of deals closed, the asset class and market for each, the projected returns vs. the actual returns at disposition or current hold, the capital preservation outcomes, and — critically — what happened in deals that underperformed relative to projections.

We do not cherry-pick our best outcomes for marketing. Healthcare professionals are trained to evaluate the full clinical picture, not just the successful cases, and we apply that same standard to our own performance reporting. If a deal projected a 16% IRR and delivered 12%, we will tell you why — what market conditions shifted, what operational decisions were made, and how capital was protected in the process. In cases where we extended a hold period or restructured a deal, we explain the reasoning and the outcome transparently.

Our philosophy is straightforward: a track record that includes honest reporting on underperformance is far more trustworthy than a curated list of highlights. The fact that we have navigated challenging situations and protected investor principal through them is, ironically, one of the strongest signals of operator competence. We are happy to walk you through every deal in our portfolio — the good, the adequate, and the instructive — on a call or in our investor packet.

We built Jacksyl Group with a deep understanding that healthcare professionals are people who manage high-stakes situations with information and communication. When you hand capital to a syndicator, you are handing over control — and silence is the fastest way to make that feel like a mistake. We will not let that happen.

Here is our communication commitment: During the active hold period, you will receive a detailed written update every quarter — not a two-paragraph email, but a substantive report covering property performance, financial statements, market conditions, any operational decisions made, and updated projections. These reports are written in plain language, not buried in jargon. Additionally, Sylvia hosts a live investor call at least once per quarter where you can ask questions directly, raise concerns, and hear from the operating team.

Outside of scheduled updates, Sylvia and our investor relations team are accessible. If you have a question, you will receive a response within 24 business hours. We also provide an annual tax preparation package including your K-1 and a summary document designed to make filing easier for you and your CPA. We treat communication as a fiduciary obligation, not a marketing activity. The investors who stay with us deal after deal consistently cite our communication as the primary reason.

We are not a volume shop. Jacksyl Group does not bring you every deal we encounter — we bring you the deals that pass our own capital standards. Sylvia underwrites every acquisition personally, and we maintain strict criteria: markets with demonstrated population growth, job diversification, and landlord-favorable regulatory environments; assets where we can identify a clear value-add thesis or a below-market acquisition opportunity; and financial structures where downside scenarios are modeled and investor principal has meaningful protection before the upside is pursued.

We say no to far more deals than we say yes to. That selectivity is by design. Our investors are high-earning healthcare professionals who have limited time and limited allocation slots for passive investments. Every opportunity we present must earn its place in your portfolio. When we bring you a deal, we include the full underwriting thesis — why this asset, why this market, why now — along with the risk factors, the projected returns under base, upside, and downside scenarios, and the exit strategy. We do not sell you on the upside and hope you forget the downside. We present the full picture so you can make the decision that fits your financial plan.

If a deal doesn't meet our standards, we don't force it. We wait. Our investors consistently tell us they prefer fewer, higher-quality opportunities over a constant stream of mediocre ones.

We have designed the investment process specifically for people who do not have time to waste. From your first expression of interest to funded investment, the process is guided, tech-enabled, and as streamlined as securities regulations allow.

Here is the high-level flow: You start by requesting access to our investor portal and completing a brief qualification questionnaire. If the current offering is appropriate for your investor profile, you receive access to the deal room — which includes the PPM, the operating agreement, the subscription documents, and a recorded walkthrough of the deal from Sylvia. All documents are available for digital review and e-signature. Accreditation verification is handled through a trusted third-party service — you upload your documentation once, and it applies to future offerings as well. Capital is wired directly to an escrow account held at a regulated bank; Jacksyl Group never holds investor funds directly.

The entire process typically takes 30 to 60 minutes of your active time, spread across a few days if you wish. We also assign a dedicated onboarding contact who can walk you through any step that feels unclear — by phone, by email, or by video. We do not assume you should navigate this alone, and we do not let administrative friction cost you a good opportunity. If something is confusing, tell us, and we will fix it or walk you through it personally.

You are a healthcare professional — which means you spent years mastering a body of knowledge that most people cannot even begin to understand. We respect that intelligence deeply, and we also recognize that intelligence in one domain does not automatically translate to fluency in private real estate syndications, preferred returns, waterfall structures, and K-1 tax reporting. That is not a reflection of your capability; it is a reflection of the fact that no one taught you this in medical or nursing school.

Our approach is: educate first, invite second. Before we ever present you with a specific deal, we make a full library of educational resources available — at no cost and with no obligation. This includes recorded webinars explaining how syndications work, written guides covering key terms and structures, short video explainers on topics like preferred return vs. equity split, and live Q&A sessions where Sylvia answers questions directly. We also offer one-on-one introductory calls where we walk you through the structure of a typical deal at whatever pace and depth you prefer.

We have found that the investors who take the time to engage with our educational content before their first investment are the most confident and the most satisfied long-term. We never want you to invest in something you don't understand — not because we are legally required to ensure your comprehension, but because an informed investor is a better partner. If there is a concept you want explained that isn't in our existing materials, ask us. If enough people ask the same question, it becomes the next resource we create.

We will tell you the worst-case scenario directly, because you deserve to hear it before you invest — not after. In any real estate syndication, the absolute worst-case scenario is total loss of invested capital. The property could suffer catastrophic damage beyond insurance coverage; the market could experience a severe downturn that eliminates the asset's value; the operating plan could fail in ways that cannot be recovered. This is the honest answer, and any operator who tells you principal is "guaranteed" in a private placement is not being honest with you.

What we can tell you — and what we do tell you in every PPM — is how we engineer risk mitigation into every deal: We acquire assets with existing cash flow, not speculative development projects, so there is revenue servicing the investment from day one. We maintain appropriate insurance coverage including liability, property, and business interruption. We underwrite conservatively, modeling downside scenarios where occupancy drops, rents decline, or exit cap rates expand — and we only proceed if the deal still protects principal under those stress cases. We structure debt conservatively, avoiding excessive leverage that amplifies downside risk. And we maintain operating reserves at the property level so that short-term disruptions do not immediately threaten distributions or principal.

When a deal underperforms — and over a portfolio, some will — our priority is capital preservation first, return optimization second. We would rather extend a hold period and exit at a recovery value than force a disposition at a loss. We have done exactly that in prior deals, and we are transparent about when and why. Honest risk disclosure builds more trust than any projected return ever will. We would rather earn your confidence with candor than your capital with promises.

This is one of the most important questions you can ask, and the answer requires you to plan carefully before investing. Syndication investments are illiquid. When you commit capital to a deal, it is deployed into a physical asset with a multi-year business plan — typically a hold period of 5 to 7 years, though some deals may be shorter or longer depending on the value-add timeline. During that hold period, there is no public market for your interest, and the operating agreement governs whether and how you can exit early.

Here is what you should know: Most of our operating agreements include provisions that allow for the transfer of your interest to an approved buyer, subject to the General Partner's consent, regulatory compliance, and administrative requirements. However, there is no guarantee that a buyer will be available, and secondary market transactions for syndication interests are limited. You should invest only capital that you can reasonably commit for the full anticipated hold period.

On the positive side, the illiquidity is precisely what enables the returns. Unlike publicly traded REITs, which must maintain liquidity at the cost of lower yields and higher volatility, private syndications allow the operator to execute a long-term business plan without the pressure of quarterly market sentiment. Distributions — typically quarterly — provide cash flow during the hold period, but you should not expect to access your invested principal until a capital event such as a refinance, a property sale, or the end of the hold period. We discuss the projected distribution schedule and hold period for every deal before you invest, and we encourage you to model the timeline against your personal liquidity needs before committing.

Tax efficiency is one of the most compelling reasons healthcare professionals invest in real estate syndications — and also one of the most complex. Here is a straightforward overview of what you need to know, with the critical caveat that we are not your CPA and you should always consult a qualified tax advisor before making investment decisions based on tax implications.

As a limited partner in a syndication, you receive a K-1 tax form each year reporting your share of the property's income, losses, depreciation, and other tax items. Real estate depreciation is a powerful tax benefit: it can shelter a significant portion of your distributions from immediate income taxation, effectively allowing you to receive cash flow that is not currently taxed as ordinary income. However, depreciation and passive loss rules are nuanced — your ability to use passive losses depends on your level of participation, your income level, and your overall tax situation. The 2024 passive activity loss rules and the material participation standards under IRS Section 469 are particularly relevant for high-earning W-2 professionals, and we strongly recommend working with a CPA who specializes in real estate taxation.

Regarding retirement accounts: Yes, you can invest through a Self-Directed IRA (SDIRA). Many of our investors do exactly that. An SDIRA is a traditional or Roth IRA held with a custodian that permits alternative investments, including private real estate syndications. The process involves establishing an SDIRA with an approved custodian, transferring or rolling over funds from your existing IRA or 401(k), and then directing the custodian to invest those funds into the syndication. Important note: if you invest through an SDIRA, all income and gains remain tax-sheltered within the IRA, but you also lose the depreciation pass-through benefit since the IRA entity cannot use passive losses. There are also prohibited transaction rules you must understand — for example, you cannot use SDIRA funds to invest in a deal where you are personally providing services or have a pre-existing relationship with the operator. We can walk you through these rules and connect you with SDIRA custodians and CPAs who work with our investor base regularly.

Yes — Sylvia invests personal capital in every deal that Jacksyl Group syndicates. This is not a philosophical position; it is a structural one. When we bring a deal to investors, the General Partner side — which includes Sylvia — has capital at risk alongside yours. The performance of the investment affects her financial outcome directly, not just through fees. This is alignment by design, not by coincidence.

Our compensation structure is transparent and documented in every operating agreement. Here is how it works: The General Partner receives an acquisition fee at closing — this is standard industry practice and covers the costs of sourcing, underwriting, and closing the deal. During the hold period, the asset management fee compensates the GP for ongoing operational management. Both fees are disclosed in the PPM, capped at specified percentages, and benchmarked against industry norms. The real alignment, however, lives in the waterfall structure. Limited Partners — you — receive your preferred return first. Only after you have received your contractual priority does the GP participate in the upside. In many of our structures, the GP does not see a promote (profit split above the preferred return) until the LP has received their full preferred return and a return of capital. Our success is literally contingent on your success.

Beyond the math, there is a question of character. Sylvia founded Jacksyl Group because she saw a gap in the market: healthcare professionals — people who work with extraordinary dedication and earn significant income — were being underserved by investment operators who didn't understand their specific needs, time constraints, and risk psychology. This firm exists to serve that community specifically. When Sylvia underwrites a deal, she asks herself one question first: Would I put my mother's retirement money into this? If the answer is anything other than a clear yes, the deal doesn't move forward. That is the standard we hold ourselves to, and we invite you to hold us to it as well.